Nifty Midcap Select PB	4.1
Nifty Midcap Select PE	29.0
Nifty Midcap Select DIV	0.8
Nifty Midcap Select EPS	438.3

Nifty Midcap Select News and Updates

Keep track of all breaking news on Nifty Midcap Select from all sources in a single place.

Load latest

YES Bank Ltd.

26 Sep 2025

21.80

0.18%

Epack Durable: YES Securities sees 50% upside in this 'undervalued' stock

Business Standard

Epack Durable share price: YES Securities values the company at 30x FY28EPS and arrives at a target price of 545

YES Bank Ltd. has gained 25.29% in the last 6 Months

Polycab India Ltd.

26 Sep 2025

7378.50

0.37%

Stocks to Watch today, Sept 26: Pharma, IT, auto, Polycab, Rites, Eternal

Business Standard

Stocks to Watch today, September 26, 2025: From Pharma, auto to Polycab, here is a list of stocks that will be in focus

Polycab India Ltd. is trading above all available SMAs

Polycab India Ltd.

25 Sep 2025

7378.50

0.37%

Polycab promoters, others sell shares worth 1,740 cr via block deals

Business Standard

Shares of Polycab India fell 1.96% to close at 7,385 apiece on the National Stock Exchange (NSE)

Polycab India Ltd. has an average target of 7635.90 from 10 brokers.

Bharat Heavy Electricals Ltd.

25 Sep 2025

244.15

1.66%

BHEL Gets DIPAM Thumbs Down For JV Plan With REC Power Arm

NDTV Profit

The JV plan, first announced in March 2024, was aimed at jointly developing utility-scale renewable energy projects across India through a special purpose vehicle.

Bharat Heavy Electricals Ltd.'s price crossed above 100Day SMA today

Muthoot Finance Ltd.

25 Sep 2025

3149.40

0.16%

Muthoot Finance shines in Q1FY26 with strong AUM, margin, gold loan growth

Business Standard

Muthoot Finance reported strong Q1FY26 results with 42% YoY AUM growth, improved asset quality, higher yields and strong recoveries as gold loans drove profitability

Muthoot Finance Ltd. has gained 61.02% in the last 1 Year

Suzlon Energy Ltd.

25 Sep 2025

54.42

-1.38%

Suzlon joins EV 100 initiative; to shift vehicle fleet to EVs by 2035

Business Line

This commitment entails Suzlon electrifying 655 vehicles across its operations, covering both owned and leased vehicles in certain categories

Suzlon Energy Ltd. has lost -31.75% in the last 1 Year

Dixon Technologies (India) Ltd.

25 Sep 2025

16480.00

0.16%

Dixon Technologies shares rise as UBS upgrades it to buy rating, sees 27% upside

Economic Times

Dixon Technologies shares: UBS upgraded the stock to a Buy' with a 23,000 target, implying ~27% upside. UBS highlighted Dixon's expansion into non-semiconductor smartphone components, expecting EBITDA margins to rise 110 bps by FY28, outperforming consensus estimates.

Dixon Technologies (India) Ltd. is trading above its 200 day SMA of 15780.3

'Buy' Dixon Technologies, Says UBS After Stock Upgrade Check Price Target, Key Stock DriversAndMore

NDTV Profit | 25 Sep 2025 1 more

Ashok Leyland Ltd.

25 Sep 2025

138.40

-2.00%

Ashok Leyland kicks off China tie-up with battery-making goal

Business Line

Ashok Leyland's collaboration with a Chinese cell-making behemoth, if successful, could serve as a test case for some of the largest Indian conglomerates

Number of FII/FPI investors increased from 747 to 786 in Jun 2025 qtr.

Ashok Leyland ties up with China's CALB to advance lithium-ion battery tech

Business Standard | 25 Sep 2025

Lupin Ltd.

24 Sep 2025

1979.60

-0.09%

Lupin gets tentative nod from USFDA for generic HIV treatment drug

Business Standard

Pharma major Lupin Ltd on Wednesday said it has received tentative approval from the US health regulator for its generic version of Bictegravir, Emtricitabine, and Tenofovir Alafenamide tablets used to treat human immunodeficiency virus (HIV) infection. The approval by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application for Bictegravir, Emtricitabine, and Tenofovir Alafenamide tablets of strength 50 mg/200 mg/25 mg, Lupin said in a regulatory filing. This product would be manufactured at Lupin's Nagpur facility, it added. Bictegravir, Emtricitabine, and Tenofovir Alafenamide tablets, 50 mg/200 mg/25 mg are bioequivalent to Biktarvy Tablets, 50 mg/200 mg/25 mg of Gilead Sciences, Inc., and indicated for the treatment of human immunodeficiency virus infection in adults and pediatric patients weighing at least 25 kg, it added. Citing IQVIA MAT July 2025 data, Lupin said the Bictegravir, Emtricitabine, and Tenofovir Alafenamide tablets (Biktarvy) had

Lupin Ltd.'s price crossed above 100Day SMA today

Polycab India Ltd.

24 Sep 2025

7378.50

0.37%

Polycab India block deal: Promoters likely to sell 0.8% stake worth Rs 887 crore on Thursday: Report

Economic Times

Promoters of Polycab India are expected to sell up to 0.81% stake through block deals, setting a floor price of Rs 7,300 per share to potentially raise Rs 887.6 crore. Several promoters, including Inder T. Jaisinghani, will participate in the sale, following a recent dip in Polycab's share price after hitting a 52-week high.

Polycab India Ltd. has gained 39.59% in the last 6 Months

Polycab Promoters To Sell 1.2 Million Shares Via Block Deal Worth Rs 880 Crore

NDTV Profit | 24 Sep 2025

Nifty Midcap Select PB

Nifty Midcap Select PE

Nifty Midcap Select DIV

Nifty Midcap Select EPS

Nifty Midcap Select News and Updates

Keep track of all breaking news on Nifty Midcap Select from all sources in a single place.